SHL - Sonic Healthcare Limited
ASX
->
Healthcare
->
Diagnostics & Research
Sydney,
Australia
Type: Equity
SHL price evolution
SHL
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $619.61 | $619.61 | $797.99 | $797.99 |
| Short term investments | ||||
| Net receivables | $1072.9 | $7005 | $6297 | $6407 |
| Inventory | $212.66 | $4294 | $4387 | $4221 |
| Total current assets | $2037.5 | $14136 | $13703 | $13027 |
| Long term investments | $170.69 | $170.69 | $175.8 | $175.8 |
| Property, plant & equipment | $2857.02 | $4210 | $4089 | $4090 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $13768.34 | $46684 | $45518 | $45312 |
| Current liabilities | ||||
| Accounts payable | $2061 | $2203 | $2060 | $2113 |
| Deferred revenue | ||||
| Short long term debt | $800.74 | $800.74 | $346.79 | $346.79 |
| Total current liabilities | $2174.17 | $13440 | $14113 | $13749 |
| Long term debt | $3188.8 | $12258 | $11117 | $11103 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $5866.11 | $28603 | $28331 | $27975 |
| Shareholders' equity | ||||
| Retained earnings | $3443.65 | $1381 | $801 | $405 |
| Other shareholder equity | $429.6 | $340 | $18 | $293 |
| Total shareholder equity | $7902.23 | $7902.23 | $7921.86 | $7921.86 |
| (in millions $) | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 | 30 Jun 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $797.99 | $780 | $899.83 | $1230.15 |
| Short term investments | ||||
| Net receivables | $1022.18 | $1217.46 | $1088.72 | $986.77 |
| Inventory | $199.2 | $216.19 | $224.39 | $163.43 |
| Total current assets | $2133.17 | $2305.91 | $2284.57 | $2455.11 |
| Long term investments | $175.8 | $145.22 | $108.11 | $91.75 |
| Property, plant & equipment | $2798.11 | $2624.86 | $2552.92 | $2498.08 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $13014.63 | $12552.01 | $11760.99 | $12127.13 |
| Current liabilities | ||||
| Accounts payable | $255.8 | $243.8 | $1026.54 | $362.03 |
| Deferred revenue | ||||
| Short long term debt | $346.79 | $342.08 | $551.43 | $663.12 |
| Total current liabilities | $1878.34 | $2084.27 | $2217.94 | $2070.13 |
| Long term debt | $2753.69 | $2670.88 | $2683.38 | $3952.76 |
| Total noncurrent liabilities | $314 | |||
| Total debt | ||||
| Total liabilities | $5092.77 | $5123.84 | $5376.01 | $6553.38 |
| Shareholders' equity | ||||
| Retained earnings | $3554.2 | $3351.02 | $2303.01 | $1318.28 |
| Other shareholder equity | $525.24 | $216.21 | $70.87 | $251.29 |
| Total shareholder equity | $7921.86 | $7428.17 | $6384.99 | $5573.75 |
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $6056 | $5201 | $5346 | |
| Cost of revenue | ||||
| Gross Profit | $2293 | $1936 | $1623 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $1435 | $1368 | $1436 | |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $235 | $65 | $33 | |
| Interest expense | -$77 | -$63 | -$43 | |
| Net income | ||||
| Net income | $537 | $445 | $105 | |
| Income (for common shares) | ||||
| (in millions $) | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 | 30 Jun 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $8168.95 | $9340.15 | $8754.12 | $6831.84 |
| Cost of revenue | $5326.53 | $5613.91 | $1616.83 | $1117.37 |
| Gross Profit | $2842.42 | $3726.24 | $7137.29 | $5714.47 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $217.02 | $270.76 | $3958.81 | $3744.34 |
| Total operating expenses | $7150.74 | $7179.78 | $6833.01 | $6019.93 |
| Operating income | $1018.21 | $2160.37 | $1921.11 | $811.91 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $223.26 | $561.74 | $480.94 | $157.16 |
| Interest expense | -$87.02 | -$79.82 | ||
| Net income | ||||
| Net income | $684.98 | $1460.57 | $1315.04 | $527.75 |
| Income (for common shares) | $684.98 | $1460.57 | $1315.04 | $527.75 |
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jun 2023 | 1 May 2023 |
|---|---|---|---|---|
| Net income | $101.16 | $151.32 | ||
| Operating activities | ||||
| Depreciation | $191.83 | $160.54 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $225.92 | |||
| Investing activities | ||||
| Capital expenditures | -$112.22 | |||
| Investments | ||||
| Total cash flows from investing | -$590.72 | -$1069 | -$402 | |
| Financing activities | ||||
| Dividends paid | -$146.96 | -$1066 | -$1066 | |
| Sale and purchase of stock | $73.41 | |||
| Net borrowings | $363.42 | |||
| Total cash flows from financing | $286.69 | -$690 | -$396 | |
| Effect of exchange rate | -$155 | -$112 | ||
| Change in cash and equivalents | -$89.19 | $205 | -$66 | |
| (in millions $) | 30 Jun 2023 | 30 Jun 2022 | 30 Oct 2021 | 30 Oct 2020 |
|---|---|---|---|---|
| Net income | $684.98 | $1460.57 | ||
| Operating activities | ||||
| Depreciation | $631.3 | $608.51 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $2225.82 | |||
| Investing activities | ||||
| Capital expenditures | -$286.95 | |||
| Investments | ||||
| Total cash flows from investing | -$989.18 | -$14140 | -$1912 | |
| Financing activities | ||||
| Dividends paid | -$455.4 | -$856 | -$798 | |
| Sale and purchase of stock | -$253.73 | |||
| Net borrowings | -$624.69 | |||
| Total cash flows from financing | -$1349.29 | $11839 | -$249 | |
| Effect of exchange rate | $34 | -$31 | ||
| Change in cash and equivalents | -$119.83 | $666 | -$264 | |
News
Fundamentals
| Market cap | $29.88B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 1.12B |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 4.00 |
| Book/Share | 6.70 |
| Cash/Share | 0.56 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.64 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.94 |
| Quick ratio | 0.84 |